Log in
Book a free demo
H-1B Data › Employers › Genzyme Corporation
Check another employer
H-1B Sponsor Profile

Genzyme Corporation — H-1B Visa Sponsorship Data

145 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.

Cambridge, MAActive FY2021–FY2026Transfer-FriendlyFull-Time RolesNot H-1B Dependent
● Data current through FY2026 · sourced from U.S. DOL OFLC, updated quarterly
I work at Genzyme CorporationSee what a DOL auditor would ask about your filingsConsidering a job here?Salaries, transfers and where roles are based
Sponsors H-1B?
Yes
145 certified LCAs
FY2026 filings
13
most recent disclosure year
Median H-1B salary
$119,000
typical $105,000–$150,701
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
31%
change-of-employer filings
Audit readiness Check another employer

4 items a DOL auditor would ask Genzyme Corporation about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Genzyme Corporation's own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.

1 need attention3 to watch2 clear
Needs attention
18 worksites across 7 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Watch
64% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 0% above the DOL prevailing wage across 59 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Watch
4 certified LCAs (4 positions) end within 180 days

Next end date: 2026-11-05. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.

Auditor asksWhich workers are on each expiring LCA, and is a superseding LCA already certified?
In your PAFSuperseding LCA, updated PAF entry and new posting notice for every position that continues.
Watch
20% of LCAs denied or withdrawn (FY2024–FY2026)

Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.

Auditor asksWere the workers on withdrawn LCAs re-covered by a valid certified LCA before continuing work?
In your PAFWithdrawal acknowledgements; superseding LCAs; PAF entries showing the transition.
Clear
8% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you Genzyme Corporation? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at Genzyme Corporation?

Does Genzyme Corporation sponsor H-1B visas?

Yes — Genzyme Corporation is an active H-1B sponsor, with 145 certified LCAs on file (FY2021–FY2026), including 13 in FY2026. The median certified salary is $119,000 (P25 $105,000, P75 $150,701). With a 31% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to Genzyme Corporation

Salary range
Median $119,000, typical band $105,000–$150,701.
Transfers
31% of filings are transfers — this employer has an established H-1B transfer track record.
Typical locations
Cambridge, MA, Framingham, MA, Philadelphia, PA, Morristown, NJ.
Position type
99.4% of filings are full-time roles.
Common roles
Associate Director, Forecasting - Rare, Medical Science Liaison, Global Scientific Communications Lead .
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. Genzyme Corporation has 145 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2026).

The median sponsored salary is $119,000, with a typical P25–P75 band of $105,000–$150,701 across certified LCAs.

Yes — 31% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

No — the employer attests it is not H-1B dependent on its LCA filings.

Genzyme Corporation filed 13 certified LCAs in FY2026, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include Cambridge, MA, Framingham, MA, Philadelphia, PA, Morristown, NJ.
Sponsorship data

Genzyme Corporation H-1B data at a glance

Executive Summary

Genzyme Corporation H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).

  • Median certified salary is $119,000, typically $105,000–$150,701 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 31% — workers actively transfer to this employer.
  • Worksite footprint spans 7 states and 18 cities.
  • Most-sponsored roles: Associate Director, Forecasting - Rare B, Medical Science Liaison, Global Scientific Communications Lead - .
  • Filed 13 certified LCAs in FY2026, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$63,000
$338,000
P25$105,000
Median$119,000
P75$150,701

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
8%
Level II
25%
Level III
21%
Level IV
46%

Levels I–IV are DOL prevailing-wage experience tiers; 67% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
32
FY2022
25
FY2023
29
FY2024
22
FY2025
24
FY2026
13
Fiscal yearCertifiedDeniedWithdrawnTotal
FY2021320436
FY2022250429
FY2023290534
FY2024220830
FY2025240529
FY2026130215

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2024 ›FY2025 ›FY2026 ›

All LCA filings

137 filings
Job titleSalaryLevelLocationFiledStatus
Safety Governance Expert
I-200-26166-013985
$100,500/yr—Cambridge, MAJun 15, 2026Certified
Associate Director of Field Sales, Analytics & Effectiveness
I-200-26142-941727
$169,541/yrIVMorristown, NJMay 22, 2026Certified
Chromatography Principal Scientist
I-200-26141-936308
$151,674/yrIVCambridge, MAMay 21, 2026Certified
Manager, Commercial Leadership Development Program
I-200-26134-911033
$122,250/yrIVCambridge, MAMay 14, 2026Certified
Principal Scientist I, Investigative Pathologist
I-200-26114-831522
$150,779/yrIVCambridge, MAApr 24, 2026Certified
Senior Director, US Commercial Insights and Analytics
I-200-26110-810559
$206,250/yrIVCambridge, MAApr 20, 2026Certified
Senior Scientist
I-200-26110-812138
$100,500/yrIFramingham, MAApr 20, 2026Certified
Sr. Product Manager - U.S. Allergy Marketing
I-200-26090-743946
$122,250/yrIVCambridge, MAMar 31, 2026Certified
Global Head of Hematology (Medical Affairs)
I-203-26068-690411
$290,000/yrIVCambridge, MAMar 09, 2026Certified
Associate Director, Forecasting Rare Blood Disorders
I-200-26057-667364
$148,500/yrIIICambridge, MAFeb 26, 2026Certified
Associate Director, Cross-Portfolio Analytics – Vaccines
I-200-26051-653863
$125,250/yrIIMorristown, NJFeb 20, 2026Certified
Systems Support Manager
I-200-25309-377579
$126,243/yr—Cambridge, MANov 05, 2025Certified
Assoc. Director, DUPIXENT Payer Analytics and Insights Lead
I-200-25309-377775
$147,000/yrIVJersey City, NJNov 05, 2025Certified
Associate Marketing Director, Dermatology Patient Marketing
I-200-25261-319099
$140,625/yrIIICambridge, MASep 18, 2025Certified
Senior Global Medical Lead
I-200-25233-257812
$225,000/yrIVCambridge, MAAug 21, 2025Certified
AI Systems & ML Scientist
I-200-25211-210546
$113,464/yrIIIFramingham, MAJul 30, 2025Certified
Director, Global Hemophilia Marketing
I-200-25203-191786
$240,053/yrIVCambridge, MAJul 22, 2025Certified
Director, National Accounts, Medical Value and Outcomes
I-200-25181-139289
$203,154/yrIVCambridge, MAJun 30, 2025Certified
Senior Manager, Advanced Analytics
I-200-25177-130808
$148,762/yrIVCambridge, MAJun 26, 2025Certified
Associate Director, Strategy and Ops, Global Immunology
I-200-25175-125092
$147,000/yr—Cambridge, MAJun 24, 2025Certified
Global Market Data Senior Manager
I-200-25164-090952
$111,966/yrIIMorristown, NJJun 13, 2025Certified
Scientist
I-200-25163-083831
$107,099/yrIICambridge, MAJun 12, 2025Certified
Senior Medical Program Manager - Pulmonology
I-200-25161-074253
$203,154/yrIVCambridge, MAJun 10, 2025Certified
Global Scientific Communications Lead - Rare Disease
I-200-25150-033722
$165,568/yrIIILos Angeles, CAMay 30, 2025Certified
Senior Manager, Forecasting
I-200-25127-949894
$111,966/yrIIMorristown, NJMay 07, 2025Certified

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How Genzyme Corporation sponsors H-1B talent

Petition Mix

New employment  25%Transfer (change of employer)  31%Continued employment  22%Amendments & other  22%
High transfer share (31%) — H-1B workers actively change employers to join Genzyme Corporation.

Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Jun and Apr — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
99.4%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Associate Director, Forecasting -
5 · $118,300
Medical Science Liaison
5 · $118,352
Global Scientific Communications L
4 · $172,380
Manager, Analytics, Rare Diseases
4 · $105,000
Safety Governance Lead
4 · $93,160

Top worksite locations

7 states · 18 cities

Cambridge, MA
114
Framingham, MA
19
Philadelphia, PA
6
Morristown, NJ
5
Northborough, MA
5
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore the H-1B compliance platform →
Explore more

Similar H-1B sponsors by filing volume

Northern Illinois University145 LCAs
Sun Cloud Llc145 LCAs
Headway Technologies, Inc.145 LCAs
Us Tiger Securities, Inc.145 LCAs
Reading Hospital145 LCAs
E-Business International Inc145 LCAs

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
Genzyme Corporation · audit readiness
1 need attention3 to watch2 clear
Get my private gap check →